M42, the global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine.
As AstraZeneca’s clinical genomics partner of choice in the Middle East region, M42 will conduct sequencing of
PureHealth, the largest healthcare platform in the Middle East, and subsidiary Abu Dhabi Health Services Company (SEHA), are set to redefine children's health services with the launch of a Paediatrics Centre in collaboration with world-renowned Cincinnati Children's, ranked first in the United States for paediatric care.
The
NYU Abu Dhabi (NYUAD), in collaboration with Tamkeen, celebrated the completion of the UAE Healthy Future Study’s (UAEHFS) first phase of recruiting nearly 15,000 participants in the UAE’s first-ever prospective cohort study of its kind that seeks to determine how the health of UAE nationals are affected by their lifestyle,
Happiness Meter
This website uses cookies. To activate this feature
